Laddar populära aktier...
Redeye saw a sales development that was better than our expectations.
Administer’s Q1 net sales declined by 3.1% y/y, driven by a 14.
Marimekko reports its Q1/24 figures 15th of May. We expect flat sales year-on-year and slightly lowe...
Performance Chemicals grows 17% as EBIT nears breakeven Cost-savings programme successful, but still...
With a new THC/CBD medical cannabis oil approved, which is ready for sales under the Danish pilot pr...
Urstark rapport från bolaget… Omsättningen i kvartalet uppgick till EUR 28m, vilket motsvarar en til...
Recorded sales improved to SEK 17.9m (10.9m in Q4 and SEK 0m in Q1 2023), and the cash balance was ...
Stabilt kvartal trots avsaknad av projektförsäljningar och låga intäkter från Lebo Arise levererade ...
New dev collaboration with MSRD on IRL757 Seeking for a partner for mesdopetam's Ph 3 Webcast today ...
Investors House reported Q1 revenues of EUR 1.6m, 4% below our 1.
Positiva topline-data Ascelia presenterade under föregående vecka topline-data från fas III-studien ...
Redeye gives an initial take on the news that IRLAB has entered into a development cooperation with ...
Redeye comments on G5’s Q1-results where topline was softer than expected while solid profitability,...
Redeye updates its view on Media and Games Invest (MGI) following its Q1 2024 report, which demonstr...
Redeye updates its estimates after reviewing Truecaller's Q1 report, which showed higher sales and p...